# A Phase I Study of a Novel Tracer for Positron Emission Tomography "PET" Myocardial Perfusion Imaging "MPI"

> **NCT02720354** · PHASE1 · COMPLETED · sponsor: **Synektik S.A.** · enrollment: 12 (actual)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **OTHER:** [11C]-DMDPA

## Key facts

- **NCT ID:** NCT02720354
- **Lead sponsor:** Synektik S.A.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-05
- **Primary completion:** 2017-02
- **Final completion:** 2017-05
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2017-10-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02720354

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02720354, "A Phase I Study of a Novel Tracer for Positron Emission Tomography "PET" Myocardial Perfusion Imaging "MPI"". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02720354. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*